The NLRP3 receptor protein is responsible for detecting potential pathogens in the body and launching an immune response. (Image by MLGProGamer123 via Wikimedia Commons)
Chronic inflammation, which results when old age, stress or environmental toxins keep the body’s immune system in overdrive, can contribute to a variety of devastating diseases, from Alzheimer’s and Parkinson’s to diabetes and cancer.
Now, scientists at the University of California, Berkeley, have identified a molecular “switch” that controls the immune machinery responsible for chronic inflammation in the body. The finding, which appears online Feb. 6 in the journal Cell Metabolism, could lead to new ways to halt or even reverse many of these age-related conditions.
“My lab is very interested in understanding the reversibility of aging,” said senior author Danica Chen, associate professor of metabolic biology, nutritional sciences and toxicology at UC Berkeley. “In the past, we showed that aged stem cells can be rejuvenated. Now, we are asking: to what extent can aging be reversed? And we are doing that by looking at physiological conditions, like inflammation and insulin resistance, that have been associated with aging-related degeneration and diseases.”
In the study, Chen and her team show that a bulky collection of immune proteins called the NLRP3 inflammasome — responsible for sensing potential threats to the body and launching an inflammation response — can be essentially switched off by removing a small bit of molecular matter in a process called deacetylation.
Overactivation of the NLRP3 inflammasome has been linked to a variety of chronic conditions, including multiple sclerosis, cancer, diabetes and dementia. Chen’s results suggest that drugs targeted toward deacetylating, or switching off, this NLRP3 inflammasome might help prevent or treat these conditions and possibly age-related degeneration in general.
“This acetylation can serve as a switch,” Chen said. “So, when it is acetylated, this inflammasome is on. When it is deacetylated, the inflammasome is off.”
By studying mice and immune cells called macrophages, the team found that a protein called SIRT2 is responsible for deacetylating the NLRP3 inflammasome. Mice that were bred with a genetic mutation that prevented them from producing SIRT2 showed more signs of inflammation at the ripe old age of two than their normal counterparts. These mice also exhibited higher insulin resistance, a condition associated with type 2 diabetes and metabolic syndrome.
The team also studied older mice whose immune systems had been destroyed with radiation and then reconstituted with blood stem cells that produced either the deacetylated or the acetylated version of the NLRP3 inflammasome. Those who were given the deacetylated, or “off,” version of the inflammasome had improved insulin resistance after six weeks, indicating that switching off this immune machinery might actually reverse the course of metabolic disease.
“I think this finding has very important implications in treating major human chronic diseases,” Chen said. “It’s also a timely question to ask, because in the past year, many promising Alzheimer’s disease trials ended in failure. One possible explanation is that treatment starts too late, and it has gone to the point of no return. So, I think it’s more urgent than ever to understand the reversibility of aging-related conditions and use that knowledge to aid a drug development for aging-related diseases.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countrieson March 20, 2020 at 6:50 am
ENIGMA was launched in December 2009 to help ‘break the logjam’ in genetic studies of the brain. At the time, most neuroimaging genetics studies were assessing historically candidate genetic ...
- Low-Carb Diet May Prevent or Even Reverse Brain Agingon March 7, 2020 at 5:04 am
Additional findings from the study included: effects of brain aging emerged at age 47, with most rapid degeneration occurring at age 60; even in adults under the age of 50, dietary ketosis ...
- Analysis of Claims Data Shows 200% Spike in Alzheimer’s, Dementiaon March 5, 2020 at 10:02 am
The gene therapy looks to treat the cellular degeneration caused by aging and is offered by Integrated Health Systems, a gene therapy facilitator used to treat various other adult aging-related ...
- Can Destroying Senescent Cells Treat Age-Related Disease?on February 29, 2020 at 9:33 pm
How aging-related cellular processes drive senescence Untangling ... and Unity is planning trials for age-related eye diseases—such as macular degeneration—with its other senolytic compounds, UBX1967 ...
- Can we turn back time on age-associated diseases?on February 28, 2020 at 6:32 am
And we are doing that by looking at physiological conditions, like inflammation and insulin resistance, that have been associated with aging-related degeneration and diseases,” explained the study’s ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Report 2020on March 20, 2020 at 5:33 pm
The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insights, Epidemiology, and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...
- Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseaseson March 20, 2020 at 5:29 am
Excessive release of neutrophil extracellular traps (NETs) is associated with disease severity and contributes to tissue injury, followed by severe organ damage. Pharmacological or genetic inhibition ...
- How Chronic Stress Changes The Brain – And What You Can Do To Reverse The Damageon March 19, 2020 at 4:43 am
Repeated stress is a major trigger for persistent inflammation in the body. Chronic inflammation can lead to a range of health problems, including diabetes and heart disease. The brain is normally ...
- Using 'organs-on-a-chip' to study chronic inflammatory diseaseson March 18, 2020 at 12:45 pm
They also discovered that a metabolic byproduct generated by bacteria living in the human gut plays an important role under these inflammatory conditions. We've shown that now you can start to attack ...
- A protein that controls inflammationon March 17, 2020 at 7:46 am
Their prevalence has been rapidly expanding over the last few decades, which means that currently millions of patients are under constant treatment with anti-inflammatory drugs to keep their condition ...